Background: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger AMPA-type glutamate receptors (AMPARs). This commonly results in Na+ and Ca2+-permeability and thereby in excitotoxic cell death of the surrounding neurons. Here we investigated how the GBM cells themselves survive in a glutamate-rich environment. Methods and Findings: In silico analysis of published reports shows down-regulation of all ionotropic glutamate receptors in GBM as compared to normal brain. In vitro, in all GBM samples tested, mRNA expression of AMPAR subunit GluR1, 2 and 4 was relatively low compared to adult and fetal total brain mRNA and adult cerebellum mRNA. These findings were in line with primary GBM samples, in which prote...
Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by its dynamic...
Growing evidence indicates that dysregulation of glutamate signaling between neurons and astrocytes ...
Targeted-therapies enhancing differentiation of glioma-initiating cells (GICs) are potential innovat...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system, ...
Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system, ...
Glioblastoma multiforme is the most malignant type of primary brain tumor with a poor prognosis. The...
The highly invasive nature of glioblastoma imposes poor prospects for patient survival. Molecular ev...
Metabotropic glutamate receptors (mGluR) are predominantly involved in maintenance of cellular homeo...
Abstract Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by it...
Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by its dynamic...
Growing evidence indicates that dysregulation of glutamate signaling between neurons and astrocytes ...
Targeted-therapies enhancing differentiation of glioma-initiating cells (GICs) are potential innovat...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
BACKGROUND: Glioblastoma multiforme (GBM) cells secrete large amounts of glutamate that can trigger ...
Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system, ...
Glioblastoma multiforme (GBM) is the most aggressive malignant tumor of the central nervous system, ...
Glioblastoma multiforme is the most malignant type of primary brain tumor with a poor prognosis. The...
The highly invasive nature of glioblastoma imposes poor prospects for patient survival. Molecular ev...
Metabotropic glutamate receptors (mGluR) are predominantly involved in maintenance of cellular homeo...
Abstract Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by it...
Glioblastoma (GBM), the most malignant tumor of the central nervous system, is marked by its dynamic...
Growing evidence indicates that dysregulation of glutamate signaling between neurons and astrocytes ...
Targeted-therapies enhancing differentiation of glioma-initiating cells (GICs) are potential innovat...